首页> 外文学位 >Detecting genetic factors associated with chronic kidney disease using multiple measures and two novel kidney function biomarkers.
【24h】

Detecting genetic factors associated with chronic kidney disease using multiple measures and two novel kidney function biomarkers.

机译:使用多种措施和两种新型肾脏功能生物标记物检测与慢性肾脏疾病相关的遗传因素。

获取原文
获取原文并翻译 | 示例

摘要

Chronic kidney disease (CKD) affects approximately 11.5% of U.S adults, and there is no sign of decline [1]. A key measure in the diagnosis of CKD is glomerular filtration rate (GFR), which is often estimated using equations based on endogenous biomarker levels. Although family studies showed that genetic factors explain about one-third of the variation in estimated GFR (eGFR), eGFR loci identified by genome-wide association studies to date explain less than 2% of the variation of eGFR on a population level. Genetic heterogeneity and the lack of precision in GFR estimates, amongst other factors, contribute the difficulties in identifying genes underlying renal function.;To partially remediate the preceding problems, Aim 1 of this thesis work used a measurement error model of GFR to examine how inclusion of multiple measures of eGFR impacts sample size and power in genetic association studies. Aims 2 and 3 were genome-wide association studies of two novel renal biomarkers, beta trace protein (BTP) and beta-2 microglobulin (B2M), conducted to understand the renal and non-renal genetic loci associated with these markers.;Results from Aim 1 showed that the use of multiple measures could lead to gain in precision, thus power; however, the gain depended greatly on the correlation structure of the errors associated with the multiple outcome measures. The work from Aim 2 followed up a novel locus of B2M in the human leukocyte antigen (HLA) region and identified classical HLA alleles that explained the GWAS signals using imputation. The work from Aim 3 identified a novel locus of BTP upstream of PTGDS, the gene that encode BTP, in European Americans and replicated this locus in African Americans. Top signals of each biomarker were not associated with creatinine-based eGFR, and, conversely, each marker was associated with a few of the GFR loci identified by previous GWASs of creatinine-based eGFR.;This thesis work improves genetic research of GFR determinants by identify ways to minimize the effect of systematic errors in detecting genetic association.
机译:慢性肾脏病(CKD)影响约11.5%的美国成年人,并且没有下降的迹象[1]。诊断CKD的关键指标是肾小球滤过率(GFR),通常使用基于内源性生物标志物水平的方程式进行估算。尽管家族研究表明遗传因素可以解释估计的GFR(eGFR)变异的三分之一,但迄今为止,通过全基因组关联研究确定的eGFR基因座在人群水平上只能解释不到2%的eGFR变异。遗传异质性和GFR估计值缺乏精确性等因素,导致难以识别肾功能的潜在基因。为了部分补救上述问题,本论文的目的1使用GFR的测量误差模型来研究eGFR的多种测量方法影响遗传关联研究中的样本量和功效。目标2和3是对两种新型肾脏生物标志物(β痕量蛋白(BTP)和β-2微球蛋白(B2M))进行的全基因组关联研究,旨在了解与这些标志物相关的肾脏和非肾脏遗传基因座。目的1表明,使用多种方法可以提高精度,从而提高功率;但是,增益很大程度上取决于与多个结果度量相关的误差的相关结构。目标2的工作追踪了人类白细胞抗原(HLA)区域中B2M的一个新基因座,并确定了经典HLA等位基因,这些基因可以通过插补解释GWAS信号。目标3的工作在欧美裔美国人中识别了PTGDS上游BTP的新基因座,该基因是BTP编码基因,并在非裔美国人中复制了这一基因座。每个生物标志物的最高信号均与基于肌酐的eGFR无关,相反,每个标志物均与先前基于肌酐的eGFR的GWAS鉴定出的一些GFR基因座相关。确定在检测遗传关联中使系统错误的影响最小化的方法。

著录项

  • 作者

    Tin, Adrienne.;

  • 作者单位

    The Johns Hopkins University.;

  • 授予单位 The Johns Hopkins University.;
  • 学科 Biology Genetics.;Health Sciences Epidemiology.
  • 学位 Ph.D.
  • 年度 2012
  • 页码 174 p.
  • 总页数 174
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号